NYSE Content Advisory: Pre-Market Update + Evommune Rises in Trading Debut
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + BETA Technologies Ends First Day of Trading Higher
NEW YORK, Nov. 5, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + BETA Technologies Raises Over $1 Billion in IPO
NEW YORK, Nov. 4, 2025 /PRNewswire/ -- The New York Stock Exchange…
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025 16:30 ET Â | Source: FibroBiologics, Inc. Advancing preparations to…
NYSE Content Advisory: Pre-Market Update + Emera Celebrates NYSE Listing
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + Fortune Celebrates Cyber 60 List
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + S&P 500 closes above 6,800 for first time
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + Grayscale Celebrates Multi Asset Crypto Fund GDLC
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market Update + International Day kicks off
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- The New York Stock Exchange…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…